Ayşe Serra Artan, Şafak Mirioğlu, Zulal İstemihan, Elif Aksoy, Ahmet Burak Dirim, Bilger Çavuş, Özgür Akın Oto, Aslı Çifçibaşı-Örmeci, Fatih Beşışık, Yaşar Çalışkan, Savaş Öztürk, Halil Yazıcı, Sabahattin Kaymakoğlu, Aydın Türkmen
BACKGROUND: Treatment using direct-acting antivirals provides high rates of sustained virologic response and a favorable safety profile for patients with chronic hepatitis C virus infection. However, data on the efficacy of direct-acting antivirals in kidney transplant recipients are still limited. AIMS: We evaluated the safety and efficacy of fixed-dose sofosbuvir/ledipasvir combination in kidney transplant recipients. STUDY DESIGN: Retrospective, observational, single-center study...
March 24, 2023: Balkan Medical Journal